957513-33-6

Upstream product

• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 26621-44-3 3-nitro-1H-pyrazole 

Downstream Products

• 1003012-19-8 4-(3-amino-pyrazol-1-ylmethyl)-benzoic acid methyl ester 
• 1033780-24-3 C₂₅H₂₅ClN₄O₆S 
• 1033780-25-4 C₂₅H₂₄Cl₂N₄O₅S 
• 1033780-02-7 (E)-4-{3-[2-(3-chloro-4-methanesulfonyl-phenyl)-2-cyclopentyloxyimino-acetylamino]-pyrazol-1-ylmethyl}-benzamide 
• 1033780-00-5 (E)-4-{3-[2-(3-chloro-4-methanesulfonyl-phenyl)-2-cyclopentyloxyimino-acetylamino]-pyrazol-1-ylmethyl}-benzoic acid methyl ester 

Relevant academic research and scientific papers

Oxime glucokinase activators

Disclosed herein are pyrazole glucokinase activators of the formula (I): that are useful for the treatment of metabolic diseases and disorders.

Pyrazole glucokinase activators

Disclosed herein are pyrazole glucokinase activators of the formula (I) useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus.